On July 8, 2026, a team of engineers and surgeons at the University of California San Diego published something that had never appeared in the medical literature before. Two humanoid robots, controlled from a distance by human operators, had completed live surgical procedures on their own. One robot worked alongside a human surgeon acting as an assistant.
The other performed a full procedure paired with a second humanoid robot, with no human hands anywhere near the operating table. Both events are described in a peer reviewed paper in the journal Nature, reported first by UC San Diego Today.
This was not a simulation and not a demonstration on a mannequin. According to the university, the procedures were performed on large, living, nonprimate mammals under real surgical conditions, and one of the two operations was a full cholecystectomy, the clinical term for a gallbladder removal, carried out from start to finish by a human robot team.
What actually happened in the operating room
The setup paired a humanoid robot, walking on two legs and reaching with two articulated arms, against a set of surgical tools normally reserved for a seated surgeon at a console. In the first case, a humanoid robot handled the instruments while a human surgeon assisted directly at the table, retracting tissue and supporting the dissection.
In the second case, described by the research team as a robot robot pairing, two humanoid units worked side by side and completed the operation without a human physically present in the room, though every motion was still directed by a remote human operator.
Dr Shanglei Liu, one of the surgeons on the project, told Newswise that a procedure carried out by a teleoperated humanoid robot showed the same level of precision as one performed with an established teleoperated surgical system, the kind already used in thousands of operating rooms worldwide.
Michael Yip, a senior author on the paper and a faculty member in UC San Diego's Department of Electrical and Computer Engineering, framed the wider goal plainly: remotely operated and eventually autonomous humanoid robots could extend critical surgical access to patients who currently have none.
The world does not have a shortage of surgical skill. It has a shortage of surgical skill in the right place at the right time. Humanoid telesurgery is an attempt to solve a geography problem, not a competence problem.
Why a robot with legs matters more than it sounds
Existing surgical robots, the kind pioneered by systems such as da Vinci, are extraordinary machines, but they are also fixed installations. A typical cart based surgical robot weighs close to 800 kilograms, needs a dedicated room layout, and represents a capital cost that only a well funded hospital can absorb.
The humanoid platform used in the UC San Diego trial, nicknamed Surgie and reportedly built on a readily available Unitree G1 chassis according to New Atlas, stands about 1.5 metres tall and weighs only 27 kilograms.
That difference in scale is the entire point. A machine that can be wheeled through a normal doorway, set up without a specialised suite, and operated remotely over a standard network connection does not need to live inside a major hospital.
It can, in principle, travel to a rural clinic, a disaster response tent, a ship, or a military field hospital, then be teleoperated by a specialist located anywhere with a stable connection.
Humanoid robot versus conventional surgical robot
| Attribute | Conventional surgical robot | Teleoperated humanoid robot |
|---|---|---|
| Typical weight | Approximately 800 kg | Approximately 27 kg |
| Typical hardware cost | USD 1 to 2.5 million per system | Built from low cost, off the shelf humanoid platforms |
| Installation setting | Dedicated operating suite | Adaptable, mobile settings |
| Mobility | Fixed arms, stationary base | Two legs, general purpose humanoid form |
| Current stage | Clinically established, in use since the early 2000s | Preclinical, proof of concept only |
Data on system pricing comes from an IndexBox market analysis of remote surgical equipment, which puts a conventional telesurgery capable system at one to two and a half million dollars, a price point that keeps this class of technology locked inside well funded urban hospitals.
The surgeon shortage this technology is trying to answer
None of this exists in a vacuum. Healthcare systems around the world are confronting a widening gap between the number of patients who need complex surgery and the number of surgeons available to perform it.
Industry analysis compiled by Grand View Research lists the global shortage of physicians and surgeons as one of the central forces pushing hospitals toward automated and remote surgical tools in the first place.
That shortage is not evenly distributed. Rural regions, low income countries, and so called medical deserts often have no local access to a trained surgeon at all, meaning patients either travel long distances at real risk to their health or simply go without treatment.
Reports from the surgical robotics sector point to demographic pressure from aging populations in regions such as Europe and Japan, combined with a persistent shortage of fellowship trained surgeons outside major cities, as a structural problem that portable, low cost robotic systems are specifically designed to address.
By the numbers
- The global surgical robots market was valued at roughly 4.3 billion dollars in 2024 and is projected to reach 9.6 billion dollars by 2033, according to Grand View Research.
- Separate analysis from Mordor Intelligence estimates the market at 8.24 billion dollars in 2025, climbing toward 13.9 billion dollars by 2031.
- Robotic assisted procedures already account for around 15 percent of total surgical volume, per market research firm Market.us.
- A conventional telesurgery capable robotic system costs between 1 million and 2.5 million dollars, restricting deployment mostly to well funded hospitals.
- Improving 5G connectivity and falling latency are repeatedly cited by market analysts as the key enablers now making remote, humanoid assisted surgery technically realistic.
The limits nobody is glossing over
Every account of the trial is careful to note that this is an early proof of concept, not a finished clinical tool. Reporting from Cryptopolitan notes the work is still slowed by recalibration between steps and network latency, the small delay between a surgeon's hand movement and the robot's response, which becomes a genuine safety concern once real tissue is involved.
Every procedure in the study required constant human oversight, and the animals used were large mammals rather than humans, meaning years of further validation, regulatory review, and clinical trials stand between this result and an actual patient.
Forbes contributor John Koetsier summarised the honest state of the technology well: today it is teleoperated and slow, but the underlying capability, a low cost general purpose humanoid performing real surgical tasks on living tissue, did not exist before this trial and now demonstrably does.
Where the humanoid robotics wave is heading next
The surgical trial arrives inside a much bigger industrial story. A Morgan Stanley report cited by New Atlas projects that China, currently the leading producer of humanoid robots, will manufacture around 446,000 humanoid units annually by 2030, with full size humanoids growing from about 30 percent of the market in 2026 to roughly 70 percent by 2028.
As that manufacturing base scales and unit costs continue falling, the economics of adapting general purpose humanoids for specialised tasks such as surgery only become more favourable.
Interesting Engineering reports that the UC San Diego team sees this early success as evidence that teleoperated and eventually semi autonomous humanoid robots could progress from assisting inside the operating room to independently performing selected procedures under remote surgeon supervision, though that step is explicitly framed as a future goal rather than a near term plan.
The bigger picture for patients
Strip away the engineering detail and the promise here is simple to state. A surgeon in a major medical centre could one day guide a lightweight, inexpensive humanoid robot located in a clinic hundreds or thousands of kilometres away, bringing a level of surgical expertise to a rural hospital, a disaster zone, or an underserved region that would otherwise be completely out of reach.
That promise is still years from a hospital near you. But for the first time, a peer reviewed study has shown that a general purpose humanoid robot can complete a real surgical procedure on living tissue while being guided entirely by a human hand from a distance, and that single fact changes what counts as plausible in the next decade of medicine.
.jpg)
.jpg)
.jpg)
0 Comments